K. Halstensen AS Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2016
NCT03538834
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

K. Halstensen AS

Active Ingredients

Drugs in Other Trials (2)

cod (1 trial)

cod protein (2 trials)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 2